Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0000805928-25-000041

Chief Innovation Officer sold 15,111 shares at $17.50 ($264,443)

  • Chief Innovation Officer acquired 32,462 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
DeVinney Erick Wayne Chief Innovation Officer 2025-03-16 Option exercise +2,950 203,361 D: show line 1 in the form
DeVinney Erick Wayne Chief Innovation Officer 2025-03-16 Option exercise +6,362 209,723 D: show line 2 in the form
DeVinney Erick Wayne Chief Innovation Officer 2025-03-16 Option exercise +23,150 232,873 D: show line 3 in the form
DeVinney Erick Wayne Chief Innovation Officer 2025-03-19 Sale −15,111 $17.50 $264,443 217,762 D: show line 4 in the form
Open-market sales · 15,111 sh · avg $17.50 · $264,443

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
DeVinney Erick Wayne Chief Innovation Officer 2025-03-16 Option exercise · Restricted Stock Units −2,950 0 D: show line 5 in the form
DeVinney Erick Wayne Chief Innovation Officer 2025-03-16 Option exercise · Restricted Stock Units −6,362 6,363 D: show line 6 in the form
DeVinney Erick Wayne Chief Innovation Officer 2025-03-16 Option exercise · Restricted Stock Units −23,150 23,150 D: show line 7 in the form
Loading xslF345X05/wk-form4_1742419444.xml…